MediWound (MDWD) Cash from Operations Growth (1y) (2014 - 2025)
MediWound (MDWD) Cash from Operations Growth (1y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - | 7.14% |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 472.89 Bn | 468.10 Bn | 1.35 Bn | 356.73% |
| 5 | Vertex Pharmaceuticals | 122.12 Bn | 114.87 Bn | 2.59 Bn | 74.39% |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.29 Bn | 3.31 Bn | 3.23% |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.90 Bn | 50.72 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn | 158.60% |
| 10 | MediWound | 166.73 Mn | 161.93 Mn | 278,000.00 | -84.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -84.24% |
| Sep 30, 2025 | 13.76% |
| Jun 30, 2025 | -58.87% |
| Mar 31, 2025 | 10.81% |
| Dec 31, 2024 | 37.40% |
| Sep 30, 2024 | -15.53% |
| Jun 30, 2024 | 31.00% |
| Mar 31, 2024 | -806.75% |
| Dec 31, 2023 | -448.67% |
| Sep 30, 2023 | 28.80% |
| Jun 30, 2023 | 0.06% |
| Mar 31, 2023 | 116.04% |
| Dec 31, 2022 | 133.56% |
| Sep 30, 2022 | -62.03% |
| Jun 30, 2022 | -433.40% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 32.62% |
| Sep 30, 2021 | -370.96% |
| Jun 30, 2021 | 65.01% |
| Mar 31, 2021 | -125.46% |